These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 29553984)
1. Averting Opioid-induced Respiratory Depression without Affecting Analgesia. Dahan A; van der Schrier R; Smith T; Aarts L; van Velzen M; Niesters M Anesthesiology; 2018 May; 128(5):1027-1037. PubMed ID: 29553984 [TBL] [Abstract][Full Text] [Related]
2. Countering opioid-induced respiratory depression by non-opioids that are respiratory stimulants. Imam MZ; Kuo A; Smith MT F1000Res; 2020; 9():. PubMed ID: 32089833 [TBL] [Abstract][Full Text] [Related]
3. Advances in Reversal Strategies of Opioid-induced Respiratory Toxicity. van der Schrier R; Dahan JDC; Boon M; Sarton E; van Velzen M; Niesters M; Dahan A Anesthesiology; 2022 Apr; 136(4):618-632. PubMed ID: 34958670 [TBL] [Abstract][Full Text] [Related]
4. Opioid-induced respiratory depression in humans: a review of pharmacokinetic-pharmacodynamic modelling of reversal. Algera MH; Kamp J; van der Schrier R; van Velzen M; Niesters M; Aarts L; Dahan A; Olofsen E Br J Anaesth; 2019 Jun; 122(6):e168-e179. PubMed ID: 30915997 [TBL] [Abstract][Full Text] [Related]
5. Two studies on reversal of opioid-induced respiratory depression by BK-channel blocker GAL021 in human volunteers. Roozekrans M; van der Schrier R; Okkerse P; Hay J; McLeod JF; Dahan A Anesthesiology; 2014 Sep; 121(3):459-68. PubMed ID: 25222672 [TBL] [Abstract][Full Text] [Related]
6. Pharmacology of viable mechanism agnostic respiratory stimulants for the reversal of drug-induced respiratory depression in humans. van Lemmen M; van der Schrier R; Dahan A; van Velzen M; Sarton E; Niesters M Expert Opin Drug Metab Toxicol; 2023; 19(10):671-679. PubMed ID: 37795596 [TBL] [Abstract][Full Text] [Related]
7. Non-analgesic effects of opioids: opioid-induced respiratory depression. Boom M; Niesters M; Sarton E; Aarts L; Smith TW; Dahan A Curr Pharm Des; 2012; 18(37):5994-6004. PubMed ID: 22747535 [TBL] [Abstract][Full Text] [Related]
8. Reversal of opioid-induced respiratory depression by BK-channel blocker GAL021: A pharmacokinetic-pharmacodynamic modeling study in healthy volunteers. Roozekrans M; Olofsen E; van der Schrier R; van Gerven J; Peng S; McLeod J; Dahan A Clin Pharmacol Ther; 2015 Jun; 97(6):641-9. PubMed ID: 25704491 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological strategy for overcoming opioid-induced ventilatory disturbances. Kimura S; Haji A Eur J Pharmacol; 2014 Feb; 725():87-90. PubMed ID: 23993949 [TBL] [Abstract][Full Text] [Related]
10. Selective antagonism of opioid-induced ventilatory depression by an ampakine molecule in humans without loss of opioid analgesia. Oertel BG; Felden L; Tran PV; Bradshaw MH; Angst MS; Schmidt H; Johnson S; Greer JJ; Geisslinger G; Varney MA; Lötsch J Clin Pharmacol Ther; 2010 Feb; 87(2):204-11. PubMed ID: 19907420 [TBL] [Abstract][Full Text] [Related]
11. Opioid-induced respiratory depression: reversal by non-opioid drugs. van der Schier R; Roozekrans M; van Velzen M; Dahan A; Niesters M F1000Prime Rep; 2014; 6():79. PubMed ID: 25343036 [TBL] [Abstract][Full Text] [Related]
12. A brain-targeted ampakine compound protects against opioid-induced respiratory depression. Dai W; Xiao D; Gao X; Zhou XB; Fang TY; Yong Z; Su RB Eur J Pharmacol; 2017 Aug; 809():122-129. PubMed ID: 28502631 [TBL] [Abstract][Full Text] [Related]
16. The specific effects of prior opioid exposure on placebo analgesia and placebo respiratory depression. Benedetti F; Amanzio M; Baldi S; Casadio C; Cavallo A; Mancuso M; Ruffini E; Oliaro A; Maggi G Pain; 1998 Apr; 75(2-3):313-9. PubMed ID: 9583767 [TBL] [Abstract][Full Text] [Related]
17. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626 [TBL] [Abstract][Full Text] [Related]
18. Respiratory depression and analgesia by opioid drugs in freely behaving larval zebrafish. Zaig S; da Silveira Scarpellini C; Montandon G Elife; 2021 Mar; 10():. PubMed ID: 33720013 [TBL] [Abstract][Full Text] [Related]
19. Ampakine CX1942 attenuates opioid-induced respiratory depression and corrects the hypoxaemic effects of etorphine in immobilized goats (Capra hircus). Haw AJ; Meyer LC; Greer JJ; Fuller A Vet Anaesth Analg; 2016 Sep; 43(5):528-38. PubMed ID: 27531058 [TBL] [Abstract][Full Text] [Related]
20. The 5-hydroxytryptamine 4 receptor agonist mosapride does not antagonize morphine-induced respiratory depression. Lötsch J; Skarke C; Schneider A; Hummel T; Geisslinger G Clin Pharmacol Ther; 2005 Sep; 78(3):278-87. PubMed ID: 16153398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]